Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for prevention of rheumatoid arthritis in seropositive arthralgia patients
NL-OMON19910Phase 3Active, not recruiting
- Sponsor
- Reade
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Development of arthritis. Started Oct 2015; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON19910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19910.